London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel (Jeremy Kahn/Fortune)
Jeremy Kahn / Fortune:
London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel — A trio of former Palantir executives who helped spearhead that company's Life Sciences practice have founded a startup called Perceptic …
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Christopher Holloway
Christopher Holloway is the founder and director of Progressive Robot, a UK-based technology company. A full-stack engineer with more than two decades of experience, he works across PHP development, ecommerce, Linux infrastructure, technical SEO and AI automation, and writes here on technology, AI, hardware and software.
Comments (0)